Circulating microenvironment of CLL: Are nurse-like cells related to tumor-associated macrophages?

• Published in: Blood cells, molecules, & diseases Vol. 50; no. 4; pp. 263 - 270
• Main Authors: Filip, Agata A., Ciseł, Bogumiła, Koczkodaj, Dorota, Wąsik-Szczepanek, Ewa, Piersiak, Tomasz, Dmoszyńska, Anna
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2013
• Subjects: Adult; Aged; Aged, 80 and over; Apoptosis; Cell Survival - genetics; Cell Survival - immunology; CLL; Female; Gene expression profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell - genetics; Leukemia, Lymphocytic, Chronic, B-Cell - immunology; Leukemia, Lymphocytic, Chronic, B-Cell - mortality; Leukemia, Lymphocytic, Chronic, B-Cell - pathology; Leukocyte Count; Macrophages - immunology; Macrophages - metabolism; Macrophages - pathology; Male; Microenvironment; Middle Aged; Neoplasm Staging; Nurse-like cells; Phagocytosis - immunology; Prognosis; Transcriptome; Tumor Microenvironment - genetics; Tumor Microenvironment - immunology; Tumor-associated macrophages; Nurse-like cells; CLL; Microenvironment; Gene expression profiling; Tumor-associated macrophages
• ISSN: 1079-9796; 1096-0961
• DOI: 10.1016/j.bcmd.2012.12.003

B-cell chronic lymphocytic leukemia (B-CLL) is one of the most common hematologic malignancies in Western countries. Accumulation of leukemic lymphocytes in peripheral blood, bone marrow and secondary lymphatic organs of CLL patients is due to decreased apoptosis rather than to increased proliferation. The former is driven by signals from a specific microenvironment, created by stromal cells of mesenchymal origin, follicular dendritic cells, T lymphocytes and others.
Nurse-like cells (NLCs) were first described to differentiate from peripheral blood mononuclear cells of CLL patients in vitro, then they have been also found in proliferation centers of their lymphatic tissues. Like tumor-associated macrophages (TAMs) in solid tumors, nurse-like cells promote survival of CLL lymphocytes. NLC gene expression patterns suggest their similarity to TAMs and differ between patients depending on ZAP70 protein expression status. NLC number in vitro corresponds with CD14 expressing cell count and beta-2-microglobulin serum level, and positively correlates with leukemic lymphocyte viability. As NLCs strongly express genes for adhesion molecules and secrete chemokines of antiapoptotic activity, they should be considered as a target for anti-microenvironment therapy of this incurable disease.